GetTopicDetailResponse(id=de8811e27587, topicName=Tivdak, introduction=, content=宮頸癌 抗體偶聯(lián)藥物 Tivdak, image=null, comments=0, allHits=761, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Tue Jul 30 13:23:15 CST 2024, time=2024-07-30, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=493838, tagList=[TagDto(tagId=493838, tagName=Tivdak)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2217532, encodeId=2da3221e5322d, content=<a href='/topic/show?id=146246308d1' target=_blank style='color:#2F92EE;'>#宮頸癌#</a> <a href='/topic/show?id=85de5518160' target=_blank style='color:#2F92EE;'>#抗體偶聯(lián)藥物#</a> <a href='/topic/show?id=de8811e27587' target=_blank style='color:#2F92EE;'>#Tivdak#</a>, objectTitle=NEJM：4倍緩解幾率！創(chuàng)新ADC療法延長(zhǎng)宮頸癌患者生存期, objectType=article, longId=836856, objectId=b791836856b7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240725/1721902488170_8538692.jpg, objectUrl=/article/show_article.do?id=b791836856b7, replyNumber=0, likeNumber=81, createdTime=2024-07-30, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b791836856b7, moduleTitle=NEJM：4倍緩解幾率！創(chuàng)新ADC療法延長(zhǎng)宮頸癌患者生存期, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b791836856b7)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-07-30發(fā)表于上海
